Clearbridge Investments LLC Sells 38,029 Shares of Tenet Healthcare Corporation $THC

Clearbridge Investments LLC trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 22.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 134,261 shares of the company’s stock after selling 38,029 shares during the quarter. Clearbridge Investments LLC’s holdings in Tenet Healthcare were worth $26,680,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. NewEdge Advisors LLC boosted its position in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after acquiring an additional 166 shares during the last quarter. Jones Financial Companies Lllp boosted its position in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after acquiring an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC acquired a new position in Tenet Healthcare during the 2nd quarter worth approximately $290,000. Quantbot Technologies LP acquired a new position in Tenet Healthcare during the 2nd quarter worth approximately $65,000. Finally, Amundi boosted its position in Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after acquiring an additional 26,383 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Stock Up 2.2%

THC opened at $166.57 on Wednesday. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21. The stock’s fifty day simple moving average is $185.02 and its 200 day simple moving average is $200.40. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The stock has a market cap of $14.35 billion, a PE ratio of 8.66, a price-to-earnings-growth ratio of 1.34 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter in the prior year, the business earned $4.36 EPS. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on THC shares. Truist Financial upped their price target on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. KeyCorp cut their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Mizuho increased their price objective on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. Robert W. Baird cut their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $244.16.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. This trade represents a 10.79% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.97% of the stock is currently owned by corporate insiders.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.